Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapeutic intervention in dementia

R E Davis1, M R Emmerling, J C Jaen

  • 1Parke-Davis Pharmaceutical Research, Warner-Lambert Co., Ann Arbor, MI 48106-1047.

Critical Reviews in Neurobiology
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Business-centric data solutions for safeguarding animal agriculture in the United States of America.

Revue scientifique et technique (International Office of Epizootics)·2023
Same author

Illegal and Therapeutic Drug Concentrations in Hair Segments - A Timetable of Drug Exposure?

Forensic science review·2015
Same author

Adverse effects of two nights of sleep restriction on the hypothalamic-pituitary-adrenal axis in healthy men.

The Journal of clinical endocrinology and metabolism·2014
Same author

Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats.

British journal of cancer·2014
Same author

[Current developments in measuring quality of life with instruments of the European organisation for research and treatment of cancer (EORTC)].

Laryngo- rhino- otologie·2011
Same author

Pharmacokinetic and pharmacodynamic evaluation of the novel CCR1 antagonist CCX354 in healthy human subjects: implications for selection of clinical dose.

Clinical pharmacology and therapeutics·2011
Same journal

Dopaminergic modulation of the neuron activity in the cerebral cortex of the wakeful animal.

Critical reviews in neurobiology·2010
Same journal

A new conceptual understanding of brain function: basic mechanisms of brain-initiated normal and pathological behaviors.

Critical reviews in neurobiology·2009
Same journal

Psychiatric implications of hepatitis-C infection.

Critical reviews in neurobiology·2009
Same journal

Methylphenidate treated at the test cage--dose-dependent sensitization or tolerance depend on the behavioral assay used.

Critical reviews in neurobiology·2009
Same journal

Cerebellar-dependent learning as a neurobehavioral index of the cannabinoid system.

Critical reviews in neurobiology·2009
Same journal

The role of intermediate filament proteins in the development of neurological disease.

Critical reviews in neurobiology·2009
See all related articles

Developing effective Alzheimer

Area of Science:

  • Neuroscience and Neurodegenerative Diseases
  • Pharmacology and Therapeutics

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by synaptic loss and cognitive decline.
  • Current treatments offer short-term symptomatic relief but do not halt disease progression.
  • The need for disease-modifying therapies is critical to alter the course of Alzheimer's disease.

Purpose of the Study:

  • To explore potential therapeutic strategies for Alzheimer's disease beyond neurotransmitter replacement.
  • To investigate the role of neurotrophic factors and amyloid plaque modulation in AD treatment.
  • To emphasize the importance of early diagnosis and multifactorial treatment approaches for Alzheimer's disease.

Main Methods:

  • Review of existing and potential therapeutic targets for Alzheimer's disease.

Related Experiment Videos

  • Discussion of agents that mimic neurotrophic factors to restore neuronal function and resilience.
  • Consideration of strategies targeting amyloid plaque biogenesis and neuroinflammation.

    • Main Results:

    • Neurotrophic factor mimetics may restore function and protect neurons from insults like excitotoxicity and oxidative stress.
    • Interventions in amyloid plaque formation and inflammation show promise for ultimate AD treatment.
    • Early diagnosis is paramount for effective intervention in the neurodegenerative process.

    Conclusions:

    • Halting synaptic loss is essential for altering the course of Alzheimer's disease.
    • Multifactorial treatment strategies, combining various approaches, are likely necessary for optimal AD therapy.
    • Early diagnosis and intervention are crucial to prevent irreversible cognitive decline in Alzheimer's disease.